Molecular structure of Etiroxate, CAS Number: 17365-01-4
Etiroxate (CAS 17365-01-4)
Alternate Names:
O-(4-Hydroxy-3,5-diiodo-phenyl)-3,5-diiodo-α-methyl-DL-tyrosine Ethyl Ester; DL-α-Methyl-thyroxine Ethyl Ester; CG-635
Application:
Etiroxate is an antilipaemic derivative of thyroxine
CAS Number:
17365-01-4
Molecular Weight:
818.95
Molecular Formula:
C18H17I4NO4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Etiroxate is an antilipemic derivative of thyroxine.
Etiroxate (CAS 17365-01-4) References
- Discrimination and molecular design of new theoretical hypolipaemic agents using the molecular connectivity functions. | Cercos-del-Pozo, RA., et al. 2000. J Chem Inf Comput Sci. 40: 178-84. PMID: 10661565
- Fragmentation of toxicologically relevant drugs in negative-ion liquid chromatography-tandem mass spectrometry. | Niessen, WM. 2012. Mass Spectrom Rev. 31: 626-65. PMID: 22829116
- Pharmacophore Model Refinement for 11β-Hydroxysteroid Dehydrogenase Inhibitors: Search for Modulators of Intracellular Glucocorticoid Concentrations. | Vuorinen, A., et al. 2014. Mol Inform. 33: 15-25. PMID: 27485195
- The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications. | Fröhlich, E. and Wahl, R. 2019. Front Neuroendocrinol. 52: 29-43. PMID: 29935915
- [The effect of repeated administration of triiodothyronine or etiroxate on liver regeneration in rats after partial hepatectomy]. | Cervinková, Z., et al. 1985. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl. 28: 291-8. PMID: 3879914
- [Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison]. | Banz, H. and Gall, FP. 1979. Fortschr Med. 97: 1942-1947. PMID: 520990
- Effect of etiroxate on LCAT activity and on certain energy metabolism enzymes in the rat. | Dobiásová, M., et al. 1982. Physiol Bohemoslov. 31: 323-7. PMID: 6215662
- Effect of triiodothyronine or etiroxate on DNA synthesis in intact and regenerating liver. | Cervinková, Z., et al. 1984. Physiol Bohemoslov. 33: 501-6. PMID: 6241723
- Rate of LCAT-mediated cholesterol esterification and serum lipids during etiroxate therapy in hyperlipoproteinemia. | Dobiásová, M., et al. 1982. Atherosclerosis. 42: 251-61. PMID: 7073804
- New Hypolipaemic Agents Designed by Molecular Topology: Pharmacological Studies of 2, 6‐Di‐tert‐butyl‐4‐methylpyridine and 2, 6‐Di‐tert‐butylpyridine | Cercós‐del‐Pozo, R. A., Pérez‐Giménez, F., Salabert‐Salvador, M. T., García‐March, F. J., & Murcia‐Soler, M. 1999. Quantitative Structure‐Activity Relationships. 18(5): 464-473.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Etiroxate, 10 mg | sc-218440 | 10 mg | $300.00 |